The FDA has approved a label expansion to Teva’s Ajovy in certain children and adolescents, making it the first migraine prevention drug of its kind in the age group.

H1 sales growth for Novo Nordisk’s segment that includes Ozempic and Wegovy was down from the same period in 2024.

Fresenius has entered into a global licensing agreement for the commercialisation of Polpharma vedolizumab biosimilar candidate PB016.

Novo Nordisk has announced the filing of 14 new lawsuits against the sale of unapproved compounded drugs claiming to contain semaglutide.

Spanning topics across R&D, clinical trials, and commercial launch, our podcast series continues as two clinical supplies ...

Agios CEO Brian Goff stated: “The SFDA’s decision marks a significant milestone, as Saudi Arabia becomes the first country to approve Pyrukynd for the treatment of adult patients with thalassemia, ...

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation between the US and the EU.

While the drugmaker reaffirmed its 2025 revenue guidance of $61bn to $64bn, it raised its full-year 2025 profit outlook. Pfizer now expects to earn $2.90 to $3.10 per share, compared with its previous ...

England has launched a world-first gonorrhoea vaccination programme that will potentially help avert up to 100,000 cases of the disease and save millions of NHS funding.

APAC-based biotech companies in Singapore, South Korea and Japan may offer investors the stability and innovation they are searching for.

Regeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects separate regulatory delays for blockbuster ophthalmology drug Eylea HD due to ...

Sandoz will acquire Just – Evotec Biologics’ biosimilar development and manufacturing plant in Toulouse for $300m.